PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Jan-2026 Nuvation Bio and Eisai Enter into Exclusive Licensing Agreement for Taletrectinib in Europe and Additional Countries Outside U.S., China and Japan Businesswire
12-Jan-2026 Vibrant Therapeutics Raises $61M and Appoints Han Lee, Ph.D. as Co-CEO Businesswire
12-Jan-2026 NeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue Businesswire
12-Jan-2026 REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight Businesswire
12-Jan-2026 TriSalus Life Sciences Announces Preliminary Fourth Quarter and Full-Year 2025 Results and 2026 Revenue Guidance Businesswire
12-Jan-2026 Ferring Pharmaceuticals and Theralase® Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer Businesswire
12-Jan-2026 SAGA Diagnostics® Launches Ultrasensitive Pathlightâ„¢ MRD Test in Colorectal Cancer Businesswire
12-Jan-2026 Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026 Businesswire
12-Jan-2026 Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production Businesswire
12-Jan-2026 Ono to Participate in the 44th Annual J.P. Morgan Healthcare Conference Businesswire
12-Jan-2026 Healthpeak Properties Announces $925 Million of Transaction Activity Businesswire
12-Jan-2026 Bristol Myers Squibb Announces Positive Topline Results from Phase 3 SCOUT-HCM Trial Evaluating Camzyos (mavacamten) in Adolescents with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) Businesswire
12-Jan-2026 Zura Bio Reports Business Updates and Outlook for 2026 Businesswire
12-Jan-2026 MedaSystems Reports Breakthrough Year of Global Growth, Clinical Trust, and Platform Expansion Businesswire
12-Jan-2026 Swiss Rockets Group and Alloy Therapeutics Partner to Advance Radioligand Therapeutics in Oncology Businesswire
12-Jan-2026 Bio-Sourcing and Zerion Pharma Join Forces to Develop First HER2 Oral Monoclonal Antibody Against Breast Cancer Businesswire
12-Jan-2026 FairJourney Bio Launches Cryo-EM Services With Advanced Laboratories in San Diego, USA Businesswire
12-Jan-2026 Jorie AI Introduces Clinically Driven Predictive Analytics to Support Proactive Care and Revenue Performance ACCESS Newswire
12-Jan-2026 The Assistance Fund Opens New Program for Colorectal Cancer ACCESS Newswire
12-Jan-2026 Shilpa Medicare targets US approval of 5-HT3 receptor antiemetic for chemotherapy-induced nausea and vomiting (CINV) shilpa medicare